TABLE 4.

Pilot Results by Country

 KenyaNigeriaSouth AfricaTanzaniaTotal
Vaginal births,a,b no.2,4462,6132,8561,6699,584
PPH cases,b no.301375512811,269
Rate of PPH cases (%) 301/2,446 (12.3)375/2,613 (14.4)512/2,856 (17.9)81/1,669 (4.9)1,269/9,584 (13.2)
Adherence of MOTIVE,b no. (%)187 (62.1)215 (57.3)55 (10.7)65 (80.2)522 (41.1)
    Massage213 (70.8)337 (89.9)278 (54.3)77 (95.1)905 (71.3)
    Oxytocin232 (77.1)336 (89.6)312 (60.9)81 (100)961 (75.7)
    Tranexamic acid218 (72.4)293 (78.1)224 (43.8)c71 (87.7)806 (63.5)
    IV fluids228 (75.7)342 (91.2)304 (59.4)78 (96.3)952 (75.0)
    Examination 213 (70.8)254 (67.7)64 (12.5)69 (85.2)600 (47.3)
Availability of drugs,d
    Oxytocin100100100100100
    Tranexamic acid10098.494.499.698.1
  • Abbreviations: IV, intravenous; MOTIVE; massage of uterus, oxytocic drugs administration, tranexamic acid administration, intravenous fluids administration, examination for identifying and managing the source of bleeding, and escalation to more advanced care, if bleeding continues despite treatment; PPH, postpartum hemorrhage.

  • a Only births with source-verified blood loss data.

  • b From individual woman’s case report form.

  • c There may have been underreporting of tranexamic acid due to confusion about naming; tranexamic acid is known as Cyclokapron in South Africa.

  • d From monthly facility-based case report forms.